TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Urologix AB
Closing information (x1000 NOK)
| Closing information | 2023/08 | 2022/08 | 2021/08 |
| Turnover |
6,780
|
7,010
|
7,152 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1,650
|
1,852
|
991 |
| EBITDA |
1,778
|
1,887
|
1,024 |
| Total assets |
2,052
|
2,198
|
2,093 |
| Current assets |
1,197
|
1,997
|
1,861 |
| Current liabilities |
504
|
529
|
359 |
| Equity capital |
1,548
|
1,669
|
1,734 |
| - share capital |
98
|
92
|
101 |
| Employees (average) |
5
|
5
|
5 |
Financial ratios
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Solvency |
75.4%
|
75.9%
|
82.8% |
| Turnover per employee |
1,356
|
1,402
|
1,430 |
| Profit as a percentage of turnover |
24.3%
|
26.4%
|
13.9% |
| Return on assets (ROA) |
80.4%
|
84.3%
|
47.3% |
| Current ratio |
237.5%
|
377.5%
|
518.4% |
| Return on equity (ROE) |
106.6%
|
111.0%
|
57.2% |
| Change turnover |
-652
|
473
|
-129 |
| Change turnover % |
-9%
|
7%
|
-2% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.